Tag | Content |
---|
EnhancerAtlas ID | HS134-40740 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr3:151110420-151112440 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXA1 | MA0148.4 | chr3:151111199-151111215 | GATTAAGTAAACATAG | + | 6.68 | FOXC1 | MA0032.2 | chr3:151111202-151111213 | TAAGTAAACAT | + | 6.02 | Foxd3 | MA0041.1 | chr3:151111613-151111625 | AAATGTTTGTTT | + | 6.27 | RREB1 | MA0073.1 | chr3:151111286-151111306 | CCCCACAACCCCCCCTCCCA | + | 6.54 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I151392 | chr3 | 151110765 | 151112413 |
|
Enhancer Sequence | CAAAACAATC TCCCACCATC ACTCACATAC AAAAACATAT GTATCTTTCC TAATCTTTCT 60 CATATATACA CACCAGTATT ATAAAGTTGT AAGGAAATGC ATAGGATAGT AAACTCCAGA 120 TTCAGAGTAG CATTTGGTAG GAGTAAGTGA GGAAAGTAAT TAGGTGTACA AAGGGCTTCA 180 GCCATATTTG TAATATTTTA TTCCAGTAGT TTCTCAGAGG TACAAGATCA TAGAGTTAGG 240 AAAATTTTTA AAAATTAGAT TATAGTTTAA TCTTTAAAAA GAATTTCCCT TTTCTGTAAA 300 TGAGTCTCTT TTTACATATC AATATACATA ATTCTTAACA CGTAATATAT GTTCTGATTG 360 TTGCTTCAAT AGAAGTTACC CAGCCATGTG TTACTTAGAT TGATCTTCTG TTTTTTTCCA 420 AATGCTCTTC AAATGCTGCT GAATGACTTT GTAAATAGAA GAAGATGGCT GAGGCAAATC 480 TCACTCATTT TAGAGGTTTC TTGTGCCAAG GTTGAGGACA TGCCTGGGAG AAAGGAACAC 540 AGAATCACAG GAACATCTCT GCTTTTTCCA AAGAGGATTT GGGGGCTTCC GTATTTAAAG 600 GGGAAAGAGT AGGCAGTAGG GGAAAGAAGA AAGAAAAAGA AGGGGAAGTA GATAAAAGGA 660 GTAAGCAGTT TCATTCTTTA GAGGCTTTGA TCAGCATTCC CTGAATCTAC ATTTTACATA 720 TGAAAGAAGC AGGTTAAAGG TTTAGTCAAT TACGGTGTTG AATCTGCATT TTTACATAAG 780 ATTAAGTAAA CATAGAGTAG AGGAAGAAGT CAAGTATATA TTTGTCTCTG ATAAGTGGAG 840 GGATGACTTC TAGTTCTGTC CTGCTCCCCC ACAACCCCCC CTCCCACCGT AAAGATAAGC 900 TGTTAATTTT AGGGTAAATC TTTTGGAACC CACAAGGAAT TTCCTTGTGA GCAAATTATG 960 AGGGAGACCT CCTAGGGAGG TATATAGCCT TCTATCTTTG TAGCTATCTA TTTAGGAAAC 1020 AAACCAGGGG ATAGTTTTGC ATGACTCAGT TCCCAACATT GACTTTTACC TTTGTCATAG 1080 TGAGTTTGGT GTCCCAAGAT TTTTAGTTTC CTTTCACAAC TTCATAAATT GTATTGCTGA 1140 TTGTGGCACT GAGTCTTTAA AAGAATGTGG GTTTTTCCAA AAAAACAGCT TTAAAATGTT 1200 TGTTTTCATC ATACACCTTG CTTTATAGAA AAGATAAAAC AACTTTTGTG AGGTGCTTAT 1260 GTAGAGGTTT TTTTCATTTA CATGTATCAA GGACTATTTT TGGTGAATGA AGAATTTACA 1320 TTTATTGTGA AGCCAGCAAA TGTCGACTTT TTTTTCCCTA ACTTTTAAAT GCGCGTGACA 1380 AATTATAATA TACAAATATG TAAAGGATTT CCTGTGGTTT CTTAAGCATC GGTATAATAG 1440 TTGCTTGTTT ATTTGATTTT TAGCCTTCAA AAAAGATGTT TTGTCATTAC AATCATAGTA 1500 CTTGAAGTTT GCAAGCATTT CAAGATTTTA AAGTATTTTC ATGCCTCTGC TATAAAACAG 1560 GCATTTTCAT TTTGCCATGG TGAAAAGACT TTAATGACAT GAGCTTCAGA TTTGATGAAA 1620 AGTACAAAAG GATTTATATG AATGGCTTAA GAACTTGGCA AAATACATCA CAAAGGCAGT 1680 ATGTTTTATA CAAGTAATAT GTTCCTGAGG GCCTTGCCTA ATTTAAAACC CATGTAATTA 1740 TGAAATTATG CCAACAACTG TATGTTTTAC ACATTTCAAT TTATGAACTG AAGACCTCCA 1800 TGAAATTAAA GTAGTATAAT TCACTTCTAC ATCACTCCCC TCATCTTTTG TAAGTTATGC 1860 AACTCAACAG GTCTATAATA TTTGTGGCAG GTGGGACAGT GCATTTTTTT CTACTTTGTT 1920 CATAAAGTGA GACTTAGAAG GTGAAATTTC TGTGTTTTGA TACATAAAAA GACCTGTTGC 1980 ATTAACGTAG TTAGAAAGTG TTTCCTTTTG GTTGCTTTTG 2020
|